{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:49:00Z","timestamp":1780102140921,"version":"3.54.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00105-023-05191-w","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T18:02:24Z","timestamp":1688407344000},"page":"782-786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multimodale Therapie des peristomalen Pyoderma gangraenosum mit topischem Ciclosporin","Multimodal therapy for peristomal pyoderma gangrenosum with topical cyclosporine"],"prefix":"10.1007","volume":"74","author":[{"given":"Anastasia S.","family":"Vollmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Toberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"5191_CR1","unstructured":"https:\/\/register.awmf.org\/assets\/guidelines\/013-091l_S1_Pyodermagangrenosum_2020-10_1.pdf, Zugegriffen 10.12.22 8:30"},{"issue":"5","key":"5191_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s40257-022-00699-8","volume":"23","author":"CA Maronese","year":"2022","unstructured":"Maronese\u00a0CA, Pimentel\u00a0MA, Li\u00a0MM, Genovese\u00a0G, Ortega-Loayza\u00a0AG, Marzano\u00a0AV (2022) Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments. Am J Clin Dermatol 23(5):615\u2013634. https:\/\/doi.org\/10.1007\/s40257-022-00699-8","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"5191_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/bjd.16401","volume":"180","author":"F Jockenh\u00f6fer","year":"2019","unstructured":"Jockenh\u00f6fer\u00a0F, Wollina\u00a0U, Salva\u00a0KA, Benson\u00a0S, Dissemond\u00a0J (2019) The PARACELSUS score: a\u00a0novel diagnostic tool for pyoderma gangrenosum. Br J Dermatol 180(3):615\u2013620. https:\/\/doi.org\/10.1111\/bjd.16401","journal-title":"Br J Dermatol"},{"issue":"3","key":"5191_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7861\/clinmedicine.19-3-224","volume":"19","author":"C George","year":"2019","unstructured":"George\u00a0C, Deroide\u00a0F, Rustin\u00a0M (2019) Pyoderma gangrenosum\u2014a\u00a0guide to diagnosis and management. Clin Med 19(3):224\u2013228. https:\/\/doi.org\/10.7861\/clinmedicine.19-3-224","journal-title":"Clin Med"},{"issue":"3","key":"5191_CR5","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/j.jaad.2015.05.010","volume":"73","author":"DL Rodenbeck","year":"2015","unstructured":"Rodenbeck\u00a0DL, Kennon\u00a0AW, Davis\u00a0LS (2015) Peristomal pyoderma gangrenosum (PG): A simple hydrocolloid dressing technique to promote wound healing. J\u00a0Am Acad Dermatol 73(3):e107\u2013e108. https:\/\/doi.org\/10.1016\/j.jaad.2015.05.010","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"5191_CR6","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.jaad.2017.12.049","volume":"78","author":"L Afifi","year":"2018","unstructured":"Afifi\u00a0L, Sanchez\u00a0IM, Wallace\u00a0MM, Braswell\u00a0SF, Ortega-Loayza\u00a0AG, Shinkai\u00a0K (2018) Diagnosis and management of peristomal pyoderma gangrenosum: a systematic review. J\u00a0Am Acad Dermatol 78(6):1195\u20131204.e1. https:\/\/doi.org\/10.1016\/j.jaad.2017.12.049","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"5191_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/039463200201500203","volume":"15","author":"C Feliciani","year":"2002","unstructured":"Feliciani\u00a0C, Tulli\u00a0A (2002) Topical cyclosporin in the treatment of dermatologic diseases. Int J Immunopathol Pharmacol 15(2):89\u201393. https:\/\/doi.org\/10.1177\/039463200201500203","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"5","key":"5191_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2133.1991.tb14783.x","volume":"125","author":"U Mrowietz","year":"1991","unstructured":"Mrowietz\u00a0U, Christophers\u00a0E (1991) Clearing of pyoderma gangrenosum by intralesional cyclosporin A. Br J Dermatol 125(5):499. https:\/\/doi.org\/10.1111\/j.1365-2133.1991.tb14783.x","journal-title":"Br J Dermatol"},{"issue":"2","key":"5191_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s001050050390","volume":"47","author":"U Theissen","year":"1996","unstructured":"Theissen\u00a0U, Luger\u00a0TA, Schwarz\u00a0T (1996) Erfolgreiche topische Anwendung von Cyclosporin A bei Pyoderma gangraenosum. Hautarzt 47(2):132\u2013135. https:\/\/doi.org\/10.1007\/s001050050390","journal-title":"Hautarzt"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05191-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-023-05191-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05191-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T13:02:08Z","timestamp":1695387728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-023-05191-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["5191"],"URL":"https:\/\/doi.org\/10.1007\/s00105-023-05191-w","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"13 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.S.\u00a0Vollmer, M.\u00a0Hartmann und F.\u00a0Toberer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}